HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Helper function of memory CD8+ T cells: heterologous CD8+ T cells support the induction of therapeutic cancer immunity.

Abstract
In contrast to the well-established efficacy of preventive vaccines, the effectiveness of therapeutic vaccines remains limited. To develop effective vaccination regimens against cancer, we have analyzed the effect of effector and memory CD8+ T cells on the ability of dendritic cells to mediate the immunologic and antitumor effects of vaccination. We show that in contrast to effector CD8+ T cells that kill antigen-carrying dendritic cells, IFNgamma-producing memory CD8+ T cells act as "helper" cells, supporting the ability of dendritic cells to produce interleukin-12 (IL-12) p70. Promoting the interaction of tumor antigen-carrying dendritic cells with memory-type "heterologous" (tumor-irrelevant) CD8+ T cells strongly enhances the IL-12p70-dependent immunogenic and therapeutic effects of vaccination in the animals bearing established tumors. Our data show that the suppressive and helper functions of CD8+ T cells are differentially expressed at different phases of CD8+ T-cell responses. Selective performance of helper functions by memory (in contrast to effector) CD8+ T cells helps to explain the phenomenon of immune memory and facilitates the design of effective therapeutic vaccines against cancer and chronic infections.
AuthorsYutaro Nakamura, Payal Watchmaker, Julie Urban, Brian Sheridan, Adam Giermasz, Fumihiko Nishimura, Kotaro Sasaki, Rachel Cumberland, Ravikumar Muthuswamy, Robbie B Mailliard, Adriana T Larregina, Louis D Falo, William Gooding, Walter J Storkus, Hideho Okada, Robert L Hendricks, Pawel Kalinski
JournalCancer research (Cancer Res) Vol. 67 Issue 20 Pg. 10012-8 (Oct 15 2007) ISSN: 0008-5472 [Print] United States
PMID17942935 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Cancer Vaccines
Topics
  • Adenocarcinoma (immunology, therapy)
  • Animals
  • CD4-Positive T-Lymphocytes (immunology)
  • CD8-Positive T-Lymphocytes (immunology)
  • Cancer Vaccines (immunology, pharmacology)
  • Colonic Neoplasms (immunology, therapy)
  • Dendritic Cells (immunology)
  • Female
  • Immunologic Memory (immunology)
  • Immunotherapy, Adoptive (methods)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • T-Lymphocytes, Cytotoxic (immunology)
  • T-Lymphocytes, Helper-Inducer (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: